drugset / Trial / NCT06535893
Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
Randomized phase II trial targeting early-stage breast cancer (stage II-III) applicable to preoperative chemotherapy (NAC), comparing standard treatment with multiple experimental treatments.
Timeline
- Start
- 2024-07-30
- Primary completion
- 2027-06-30
- Completion
- 2040-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Niraparib | Small molecule | — | — |
| Background | Carboplatin | Small molecule | — | — |
| Background | Paclitaxel | Small molecule | — | — |
| Background | Pembrolizumab | Monoclonal antibody | — | — |